Galactofuranose (Galf ) is the five-membered ring form of galactose. It is widely distributed among several branches of the eukaryotic kingdom. This review highlights recent advances in our understanding of the biosynthesis and function of Galf-containing glycoconjugates in fungal Aspergillus spp. and the protozoan trypanosomatid parasites. We give an overview of the biosynthetic pathways leading to the production of glycolipids, glycoproteins and polysaccharides containing Galf in these species and their biological relevance. Remarkably, modification of the cell surface caused by Galf absence often results in morphological abnormalities and an impaired cell wall function in these organisms. Galf-deficient mutants are generally hypersensitive to drugs, exhibit a constitutive osmotic stress phenotype and/or have an attenuated virulence. Since Galf has never been found in mammals and higher plants, Galf-biosynthetic pathways have raised much interest as targets for drug development to combat microbial infections.
Introduction
Polysaccharides and glycoconjugates play important roles in many biological events. Typically, they are present at the cell membrane, cell wall or are secreted in the extracellular space, where they form the interface between a cell or an organism and its environment enabling cell-cell interactions and signaling events.
Galactose is a common monosaccharide which in mammals is found exclusively in the hexopyranosyl form (Galp). In contrast, in many other organisms, notably bacteria, fungi, protozoa, starfish, sponges and green algae (Peltier et al. 2008) , galactose is frequently found in the cyclic hemiacetal form with a five-membered ring, galactofuranose (Galf ), which in solution exists in equilibrium with Galp ( Figure 1 ). The ubiquitous presence of Galf in non-mammalian species is remarkable, since the Galf form is thermodynamically less favorable than its pyranose form due to increased steric interactions in five-membered rings, compared with six-membered rings (Collins and Ferrier 1995) . Galf is found in many pathogenic species, suggesting that it may be advantageous to express Galf, e.g. as an important element for survival. Since Galf has never been found in mammals, Galf-biosynthetic pathways have raised much interest as targets for drug development to combat parasitic and fungal infections as reviewed in de Lederkremer and Colli (1995) and Pedersen and Turco (2003) .
In this review, we do not aim to give a complete overview of all Galf-containing structures in different species, but rather will illustrate the presence of major structures found in two different classes of eukaryotes, fungi and protozoa, and discuss the biosynthesis and biological significance of Galf-containing compounds in relation to the pathogenicity of these species or their potential biotechnological relevance. We thereby will focus mainly on pathogenic organisms, such as the opportunistic fungal pathogen Aspergillus fumigatus and the parasites Leishmania and Trypanosoma, and on the fungus Aspergillus niger, which is commercially used to produce food and pharmaceutical proteins.
Galf in fungal species
Galf is an essential substituent of the cell wall of many fungi and is also present in secreted molecules. These fungi may be parasitic or saprophytic and include many species that cause allergic or invasive diseases or are of industrial importance. The structures found among fungal polysaccharides are interrelated but show species-specific differences, and the content and linkage types found for Galf contribute to chemotaxonomic classification of fungi (Ahrazem et al. 1997; Leal and Bernabe 1998) .
The distribution of genes involved in UDP (uridine diphosphate)-Galf synthesis and transport suggests that this monosaccharide is present in all genera belonging to the Pezizomycotina subphylum within the Ascomycota phylum ( Figure 2 ). Galf has also been directly evidenced in numerous Ascomycota such as Penicillium (Preston and Gander 1968) , Aspergillus (Reiss and Lehmann 1979; Stynen et al. 1992) , Paracoccidioides (Levery et al. 1998) , Histoplasma (Barr et al. 1984) and Fonsecaea (Shibata and Okawa 2011; Figure 2 ). Using a Galf-specific antibody, it was detected in germlings, vegetative cells and young conidia of Aspergillus, indicating expression at the different stages of filamentous fungi (Stynen et al. 1992) . The presence of Galf has also been described in Basidiomycota such as Cryptococcus neoformans (James and Cherniak 1992) and is confirmed by bioinformatic analysis (Figure 2 ). In contrast, yeast-like species like Saccharomyces cerevisiae, Schizosaccharomyces pombe and Pichia pastoris, belonging to the Taphrinomycotina and Saccharomycotina subphylums within the Ascomycota do not express any Galf (Figure 2 ). Galf has also been reported in some lichens, composite organisms consisting of a symbiotic association of a fungus with a photosynthetic partner (green alga or cyanobacterium). In the lichens, it has been found as a constituent of the green algae (Cordeiro et al. 2005 (Cordeiro et al. , 2007 Sassaki et al. 2005 ), a finding, that is in agreement with the presence of Galf in the O-glycans of the free-living alga Chlamydomonas reinhardtii (Bollig et al. 2007) .
Galf in the cell wall of Aspergillus spp. The fungal cell wall prevents the lysis of the cell from internal turgor pressure and is able to respond to environmental changes by dynamic modification of its composition. For pathogenic fungi, it is a target for the host immune system, and its molecular composition is a key factor in determining the interaction with host receptors, thereby influencing the outcome of the immune response. The cell wall is mainly composed of polysaccharide structures, including glucans, chitin and (galacto)mannans (Klis et al. 2007; Latge 2007) . These large polymers are often interconnected to form more complex structures. Other structural components of the fungal cell wall are glycoproteins, containing either O-and/or N-linked glycans (Wallis, Swift, et al. 1999; Morelle et al. 2005) .
Glycoproteins are present at various locations at the outside of the cell: they can be attached to the cell membrane either via transmembrane domains or via a glycosylphosphatidylinositol (GPI) anchor, they can be covalently linked to the glucan part of the cell wall or glycoproteins can be secreted into the medium. Studies on the structure of these glycoconjugates have provided a better understanding of the composition of the cell wall; however, many aspects of their biosynthesis and the way the different glycoconjugates are interconnected within the cell wall are not well understood. Remarkably, around 5% of the dry weight of A. fumigatus consists of Galf, indicating that this monosaccharide is quite abundant in Aspergilli (Lamarre et al. 2009 ). Galf has been identified as a component of the galactomannan fraction in the cell wall of Aspergilli, as a part of N-and O-glycans of extracellular proteins and within glycosphingolipids (Bardalaye and Nordin 1977; Baretto-Bergter et al. 1980; Wallis, Swift, et al. 1999; Toledo et al. 2010) .
Galf in galactomannan of Aspergilli
Galactomannan is a polysaccharide composed of a mannancore structure with galactose (Galp or Galf ) side chains. In A. fumigatus, the galactomannan is either covalently attached to β1,3 glucans of the cell wall or linked to the plasma membrane via a GPI anchor (Costachel et al. 2005) . It is also shed from the cell wall as a free (soluble) polysaccharide in the medium (Fontaine et al. 2000) . Typically, Galf has been described to occur in the galactomannan as side chains with repeating β5-Galf units that are β3,6 linked to the mannose backbone (Latge et al. 1994 ; Figure 3A ). However, variations in this structure have been reported which differ both in the mannan core and in the Galf side chains (Bardalaye and Nordin 1977; Baretto-Bergter et al. 1980; Leal et al. 1992; Latge et al. 1994) . The observed differences may be due to variations between strains and culture conditions used; however, variations in the purity of the galactomannan and the methods used for structural analysis and their interpretation cannot be excluded.
In the lipogalactomannan, the galactomannan is attached to a GPI moiety, which anchors it to the cell membrane (Costachel et al. 2005) . The glycan structure of the anchor Manα1,2Manα1,2Manα1,6Manα1,4GlcNH 2 is α1,6 linked to an inositol phosphoceramide, containing mainly C18-phytosphingosine and monohydroxylated lignoceric acid. The galactomannan structure is thought to be linked to the terminal mannose of the anchor (Costachel et al. 2005) .
Galf in glycoproteins in Aspergilli
In addition to the galactomannan, glycoproteins have been shown to contain Galf. The structural characterization of protein-linked glycans showed the presence of Galf in both N-and O-linked glycans in Aspergillus. In contrast to Fig. 1 . The equilibrium in solution between Galf and Galp. Both cyclic forms of galactose are in equilibrium with the linear form. The equilibrium is heavily in favor of the six-membered Galp form, as indicated by the arrows. The C-atoms involved in the formation of both cyclic forms are indicated with numbers.
Galactofuranose in eukaryotes Fig. 2 . Occurrence of Galf biosynthetic genes in the fungal kingdom. Database searches were conducted in the indicated fungal genomes using A. fumigatus glfA (encoding the enzyme synthesizing UDP-Galf ), and glfB (encoding the UDP-Galf transporter) as query. The presence of homologs of glfA and glfB in the genome and their chromosomal distance is highlighted by superscripts. 1 indicates the adjacent genes; 2 indicates the genes in close proximity, whereas 3 designates the distant genes. Other species depicted here do not present any glfA and glfB homologs. ascomycetous yeasts, Aspergilli express relatively short Nglycans. Detailed analysis of the N-glycans of α-D-galactosidase (Takayanagi et al. 1992 ) and α-D-glucosidase from A. niger (Takayanagi et al. 1994 ) by nuclear magnetic resonance (NMR) revealed the presence of GalfMan 5-8 GlcNAc 2 structures with a Galf residue in a terminal non-reducing position α1,2 linked to mannose as depicted in Figure 3B . However, western blot analysis with the monoclonal antibody (mAb) EB-A2, which recognizes β-linked Galf (Stynen et al. 1992) , and the cleavage by β-galactofuranosidase (Wallis et al. 2001b) suggest that some of the Galf residues on A. niger α-D-galactosidase are attached to the N-glycan in the β-linkage. The presence of a terminal β-Galf was also described in the N-glycans of A. fumigatus phospholipase C and phytase. Linkage analysis by gas chromatography (GC) mass spectrometry (MS) suggests that Galf is attached in a 1,2 linkage to mannose on these two proteins (Morelle et al. 2005) . Finally, the analysis of N-glycans from A. fumigatus secreted proteins by capillary electrophoresis combined with digestion with A. saitoi α1,2 mannosidase or jack-bean mannosidase revealed that the Galf is not substituting an α1,2-linked mannose (Schmalhorst et al. 2008) . Larger N-glycans containing up to 23 mannose residues have also been reported in Aspergilli (Wallis et al. 2001a; Morelle et al. 2005) . They might be synthesized in specific environmental conditions and involved the fungal OchA protein (Kotz et al. 2010a) . Remarkably, A. niger glucoamylase, a major secreted glycoprotein involved in the breakdown of starch, is reported to lack Galf on its N-glycans (Wallis, Swift, et al. 1999 ). However, this protein contains a stretch of more than 30 O-linked oligomannoses in the vicinity of the starch-binding domain (Sauer et al. 2000) that are recognized by the EB-A2 antibody, suggesting the presence of β-linked Galf residues (Wallis, Swift, et al. 1999 ). Galf has also been shown within O-linked glycans of the cell wall peptidogalactomannan of A. fumigatus (Leitao et al. 2003) . Methylation analysis, MS, NMR and GC identified terminal Galfβ1, 6, Galfβ1, 5Galfβ1, 6 and Galfβ1, 5[Galfβ1, 5] 3 Galfβ1,6 structures, linked to one mannose or to a mannose disaccharide ( Figure 3C ). Thus far, no Galf moieties have been identified in GPI anchors of proteins in Aspergillus spp. Fig. 3 . Different Galf-containing glycoconjugates found in Aspergillus spp. Glycoside linkages are indicated and monosaccharides are represented by the conventional symbols as defined in the figure. Galactomannan (A) has been found in a soluble form, covalently bound to β-glucan and attached to a GPI anchor. n indicates the average length. N-glycans, containing Galf (B), are covalently linked to the protein backbone via an asparagine (Asn) residue. An N-glycan containing eight mannose residues is depicted here, but shorter N-glycans with 5, 6 or 7 mannoses have also been characterized. The asterisk indicates that β-linked Galf have also been found on N-glycans. Galf-containing O-glycans (C) are covalently linked to the protein backbone via a serine (Ser) or threonine (Thr) residue. Galf-containing glycosphingolipids (D) identified in A. fumigatus. +/-indicates that this moiety can be present or absent.
Galactofuranose in eukaryotes
Galf in fungal lipid-linked glycans Galf has also been demonstrated in glycosylinositolphosphoceramides (GIPCs), acidic glycosphingolipids containing a phosphodiester linkage between inositol and ceramide. The inositolphosphorylceramide synthase is essential for the growth of Aspergilli but elongation with α1,2 mannose is dispensable for A. fumigatus growth and virulence (Kotz et al. 2010b) . In Aspergillus nidulans, the biosynthesis of GIPC has been shown to be essential for polarized growth (Cheng et al. 2001) . Galf has been detected as a component of GIPC in A. fumigatus by NMR and MS. In these structures, Galf is found in both β1,2 and β1,6 linkages to a short oligomannose backbone ( Figure 3D ; Toledo et al. 2007; Simenel et al. 2008) . Interestingly, the terminal β1,2-linked Galf can also be modified with a phosphorylcholine (PC) moiety (Simenel et al. 2008) . PC is a common glycan modification in nematodes, within both glycosphingolipids and glycoproteins, and PC-modified glycans are known to have distinct immunomodulatory properties (Grabitzki and Lochnit 2009) .
The β-linked Galf residues on Aspergillus GIPC are not recognized by mAb EB-A2 (Latge 2009 ), but another mAb, MEST-1, recognizes the β1,6-linked Galf on these lipids, similarly as in other fungi such as the dimorphic pathogenic fungi Paracoccidioides brasiliensis, responsible for paracoccidioidomycosis and Histoplasma capsulatum, the causative agent of histoplasmosis (Suzuki et al. 1997) . Summarizing, the current data reveal that in Aspergillus spp. Galf may be present as terminal residues within N-glycans and is linked either in α1,2 or β1,2 to mannose. In addition, Galf may occur within the galactomannan in β1,3-and β1,5-linkage types, in β1,5 and β1,6 in O-glycans and in β1,2 and β1,6 linkages within glycosphingolipids.
Galf in protozoan trypanosomatids
Trypanosomatids are parasitic protozoa that have a single flagellum. Two major groups are distinguished, the monogenetic trypanosomatids infecting only an insect host, and the digenetic trypanosomatids that can infect a secondary host, often vertebrates. The digenetic trypanosomatids of the genus Trypanosoma and Leishmania are responsible for human diseases. Trypanosoma brucei and Trypanosoma cruzi cause the Sleeping Sickness in Africa and Chagas disease in South America, respectively, and more than 20 Leishmania species are responsible for cutaneous, mucocutaneous or visceral leishmaniasis in tropical and subtropical areas of the world. Visceral leishmaniasis is the second-leading cause of parasite-related deaths after malaria (Ameen 2010) . Trypanosoma and Leishmania alternate between an insect vector and a mammalian host and present different stages. In the insects, promastigote, epimastigote and trypomastigote are typically found, whereas in the mammalian, host bloodstream trypomastigote and intracellular amastigote are distinguished. During the differentiation of the parasites, many surface changes involving carbohydrate structures occur and contribute to the parasite's capacity to infect their hosts and to counteract or evade the host immune system. The presence of Galf in protozoa was first reported in the early 1980s (de Lederkremer et al. 1980) and is illustrated by findings that sera from patients with Chagas disease could precipitate β-Galf-containing galactomannans from A. fumigatus and Dactylium dendroides (Schnaidman et al. 1986 ). In addition, cross-reactivity between fungal and protozoan glycolipids has been found by an mAb (MEST-1), which recognizes β-linked Galf on the fungus P. brasiliensis, as well as on promastigotes of Leishmania major and epimastigotes of T. cruzi (Suzuki et al. 1997 ). More recently, the measurement of the nucleotide-sugar pools in trypanosomatids demonstrated the absence of UDP-Galf, the biosynthetic precursor of galactofuranosylated molecules, in T. brucei and highlighted its presence in T. cruzi and L. major (Turnock and Ferguson 2007) . This distribution is in agreement with the structural analyses of glycoconjugates of these parasites as summarized below.
Galf in trypanosomatid glycoproteins
Early work demonstrated the presence of Galf in N-linked, high-mannose-type oligosaccharides of several monogenetic trypanosomatids (Crithidia fasciculata, C. harmosa, Leptomonas samueli and Herpetomonas samuelpessoai), as well as in the digenetic parasites T. cruzi and Endotrypanum schaudini (Parodi 1993; de Lederkremer and Colli 1995) . The Galf moiety was found β-linked to external mannose residues; however, the linkage type has not been described. In T. cruzi, the phosphoglycans modifying the membrane protein gp72 also contains Galf as well as α-L-fucose, α-L-rhamnose, β-D-xylose, N-acetylglucosamine and Galp, but their detailed structures have not been elucidated (Haynes et al. 1996) . Finally, the O-linked oligosaccharides of mucin-like proteins have received much interest due to their association with trans-sialidation and the infectivity of the parasite (Agusti et al. 2007; Eugenia Giorgi and de Lederkremer 2011) . The presence of Galf in these O-linked oligosaccharides is straindependent and found in the mucin-like proteins produced by the G Serrano et al. 1995) , Dm28c (Agrellos et al. 2003) and Tulahen strains (Jones et al. 2004) as reviewed by de Lederkremer and Agusti (2009) . Substitution by Neu5Ac and Galf, as indicated in Figure 4A , has been described in strain Dm28c. Alternatively, the Galfβ1,4GlcNAc-O-Thr core can be further extended by a β1,2-linked Galp or Galf and addition of several Galp residues. The most complex of the structures described are depicted in Figure 4A .
Galf in trypanosomatid lipid-linked glycans A highly abundant class of free GPI referred to as glycoinositolphospholipids (GIPLs) cover the surface of numerous trypanosomatids. In T. cruzi, the principal GIPL and major component at the surface of the insect stage are called lipopeptidophosphoglycan (LPPG) and contain Galf (de Lederkremer et al. 1980 , 1991 , 1993 Previato et al. 1990 ). This name originates from the small amount of peptide frequently present in purified fractions. The glycan structure of LPPG, depicted in Figure 4B , contains the same backbone sequence as GPI anchors of proteins and one or two terminal Galfβ3-Man moieties which contribute to the antigenicity of these compounds (de Lederkremer et al. 1980 (de Lederkremer et al. , 1991 Mendonca-Previato et al. 1983; Previato et al. 1990 ). In Leishmania, Galf residues have been described in the anchor of the virulence factor lipophosphoglycan (LPG) that dominates the surface of the insect stage of all Leishmania species, as well as in the GIPLs of L. major (Turco and Descoteaux 1992) . The LPG membrane anchor is highly conserved and is extraordinary in containing an internal Galfβ1,3Man moiety in the glycan core (McConville et al. 1987 (McConville et al. , 1990 Orlandi and Turco 1987; Turco et al. 1989) . With the exception of an α-D-glucose-phosphate residue that may substitute the six positions of the distal mannose, the LPG anchor presents the same core structure as the most complex GIPL of L. major, termed GIPL-3 since it contains three galactose residues ( Figure 4B ). In addition, L. major synthesizes shorter GIPLs containing one or two galactose residues (McConville et al. 1990 (McConville et al. , 1993 . Interestingly, the same GIPLs have been described in the digenetic parasite Leishmania adleri that infects lizard (Routier et al. 1994; Previato et al. 1997) . Other examples of monogenetic or digenetic trypanosomatids that contain Galf in their surface GIPLs are L. samueli (Previato et al. 1992) or E. schaudini (Xavier Da Silveira et al. 1998 ).
Biosynthesis of Galf-containing glycoconjugates
The biosynthesis of glycans is a non-template driven process, requiring the action of many glycosyltransferases, enzymes that catalyze the transfer of a monosaccharide from an activated sugar to a growing glycan. In addition, glycan biosynthesis requires enzymes responsible for the synthesis of activated sugar donors and transporters that ensure substrate availability in the proper cellular compartment. The biosynthesis of Galf-containing carbohydrates starts with the synthesis of nucleotide-sugar donor UDP-Galf. Hereafter, transport into the lumen of the Golgi is needed for subsequent elongation of the glycans by Galf transferases. Based on the different Galf-containing structures, it may be expected that multiple putative Galf transferases will contribute to the synthesis of the different glycoconjugates. Finally, all glycoconjugates should be transported to the cell surface from where they are eventually transferred to the cell wall, or released into the extracellular space.
UDP-Galf biosynthesis UDP-Galf is essential for the biosynthesis of all glycoconjugates containing a Galf moiety and originates directly from UDP-Galp. UDP-Galp is generated by the epimerization of UDP-glucose by UDP-glucose-4-epimerase (UGE) (also called UDP-galactose-4-epimerase) and by the salvage of galactose. In many organisms, galactose salvage occurs via the Leloir pathway which provides a unique means for cells to use galactose as a carbon and energy source (Frey 1996) . Galactose is first phosphorylated by a galactokinase (encoded by GALK). The resulting Gal-1-phosphate and UDP-Glc are subsequently converted by the enzyme UDP-glucose:α-D-galactose-1-phosphate uridylyltransferase (encoded by GALT) into UDP-Galp and glucose-1-phosphate, the latter being then metabolized through glycolysis (Frey 1996) . The sialylated structure (I) has been found in T. cruzi Dm28c, whereas the other structures are described for several different strains. The asterisks next to the β6-linked galactose chain (II and IV) are placed to indicate that this chain can be present as a tri-, di-or monosaccharide, or even be absent. GIPLs (B) from T. cruzi (I) and L. major (II) and the core structure of LPG from Leishmania (III). +/-indicates that this moiety can be present or absent.
Galactofuranose in eukaryotes
Plants present an additional pathway that allows the direct activation of Galp-1-phosphate with UTP by the UTP-monosaccharide-1-phosphate uridylyltransferase, also called UDP-sugar pyrophosphorylase (USP; Kotake et al. 2004 ). Interestingly, this enzyme but not the Leloir enzyme is present in the protozoan parasites Leishmania spp. and T. cruzi Dickmanns et al. 2010; Lamerz et al. 2010; Yang and Bar-Peled 2010) . USP is thought to mediate galactose salvage in Leishmania species Dickmanns et al. 2010; Lamerz et al. 2010) , but its role in T. cruzi is more obscure since trypanosomes are unable to transport galactose across the plasma membrane and seem to rely exclusively on UGE for the synthesis of UDP-Galp (MacRae et al. 2006) . UDP-Galp is converted into the furanose form by the cytosolic enzyme UDP-Galp mutase (UGM). The gene encoding UGM called glf or ugm has been identified and characterized in several eukaryotes, including Aspergillus spp. (Damveld et al. 2008; El-Ganiny et al. 2008; Schmalhorst et al. 2008) , L. major (Bakker, Kleczka, et al. 2005; Beverley et al. 2005; Kleczka et al. 2007 ) and Caenorhabditis elegans (Novelli et al. 2009 ). Several species contain close homologs of the glf gene including numerous fungi (Figure 2) , the algae C. reinhardtii, the parasitic nematode Brugia malayi and the urochordates Halocynthia and Cionia intestinalis, as was found in recent BLAST searches done by the authors. Although the presence of glf homologs is not always corroborated by structural evidence of the Galf presence, the glf gene distribution suggests that Galf synthesis occurs broadly throughout the eukaryotic kingdom, but is absent from mammals and higher plants.
Since UGM is essential for mycobacterial growth, it has been extensively studied in prokaryotes. The equilibrium of the enzymatic reaction is heavily in favor of UDP-Galp (93%). An excellent review on the mechanism by which this flavincontaining enzyme likely performs its function has appeared recently (Richards and Lowary 2009) . Moreover, Escherichia coli, Mycobacterium tuberculosis and Klebsiella pneumoniae UGMs have been crystallized in both the active (reduced) state and the inactive (oxidized) state and the interaction with its substrates studied by fluorescence, NMR and X-ray crystallography (Sanders et al. 2001; Beis et al. 2005) . In contrast, eukaryotic UGMs have been described fairly recently and information about these enzymes is still limited. At the primary sequence level, conservation between prokaryotic and eukaryotic UGM is low (less than 15% identity), although many residues involved in FAD and UDP-Galp binding are conserved. Oppenheimer and colleagues recently suggested that A. fumigatus UGM employs a different mechanism of substrate binding compared with bacterial UGMs. Moreover, fungal UGMs function as tetramers (Oppenheimer et al. 2010 ), whereas L. major functions as a monomer (Oppenheimer et al. 2011 ) and hence differ from the dimeric bacterial UGMs. The kinetic parameters of eukaryotic UGMs are however similar to bacterial enzymes (Oppenheimer et al. 2010 ).
UDP-Galf transport into the Golgi
The biosynthesis of UDP-Galf has been shown to occur in the cytosol (Kleczka et al. 2007; Novelli et al. 2009 ). However, the biosynthesis of galactofuranosylated carbohydrates such as N-or O-glycans or glycolipids is expected to occur in the lumen of the Golgi apparatus.
UDP-Galf must thus be first transported into the Golgi lumen by a specific nucleotide-sugar transporter. Recently, such a UDP-Galf transporter (GlfB) has been identified in A. fumigatus and localized to the Golgi equivalent (Engel et al. 2009 ). This transporter shares 20% identity with two Arabidopsis thaliana UDP-Galp transporters ), which represent the most similar proteins with known function. Analysis of glycoproteins, glycolipids and galactomannans of the A. fumigatus glfB knockout strain revealed that none of these compounds contain Galf moieties. This indicates that in A. fumigatus the biosynthetic pathways for all Galf-containing carbohydrates are dependent on GlfB. The UDP-Galf transporter has also been functionally characterized in A. nidulans (Afroz et al. 2011 ). The transporter was identified because of its high homology with the A. fumigatus GlfB protein. Like in A. fumigatus, the UGM and the UDP-Galf transporter are clustered. The deletion of the UDP-Galf transporter in A. nidulans (encoded by the ugtA gene) confirmed that ugtA is required for galactofuranosylation. By tagging the UgtA protein with green fluorescent protein, the UgtA protein was found to be localized in the Golgi apparatus (Afroz et al. 2011) . Interestingly, an UDP-Galf transporter (glfB/ugtA) seems to be present in all filamentous fungi of the subphylum Pezizomycotina and is directly adjacent or in close proximity to the glfA/ugmA gene, encoding the UGM (Figure 2 ). In contrast, the two genes glfA and glfB are often more distant in basidiomycota (Figure 2) . The continuous effort made to sequence fungal genomes will determine if these observations can be generalized in the future.
Putative UDP-galactofuranosyltransferases
To enable a better understanding of the role of individual Galf-containing glycoconjugates in cell wall biosynthesis or pathogenesis, it is necessary to identify and characterize the Galf transferases that catalyze the addition of Galf from UDP-Galf to the respective acceptor substrates. Until now, L. major LPG1 is the only putative Galf transferase described in eukaryotes. The LPG1 gene was identified by functional complementation of the Leishmania donovani R2D2 mutant (Ryan et al. 1993 ) and was later deleted in Leishmania mexicana (Ilg 2000) and L. major (Spath et al. 2000) . The mutants were devoid of the abundant cell surface LPG and the remaining core structure revealed the likely role of LPG1 in the Galf transfer. LPG1 encodes a putative β1,3Galf transferase acting on the GPI-like molecule Manα1,3Manα1,4GlcNα1,6PI and is classified in the CAZy glycosyltransferase family 40. Interestingly, Galf-containing GIPLs were maintained in LPG1-deficient L. major indicating that LPG1 is selective for a subpopulation of GPI substrates and underlining the requirement for additional Galf transferase (s) (Spath et al. 2000; Kleczka et al. 2007 ). The Leishmania genome encodes at least three putative Galf transferase homologous to LPG1 named LPG1L, LPG1R and LPG1G, whose functions are still undefined. These might be involved in protein glycosylation or, in the case of LPG1G, in GIPL biosynthesis (Zhang et al. 2004 ). Homologs of these putative Galf transferases are exclusively found in closely related trypanosomatids, including T. cruzi, Crithidia, Leptomonas and Endotrypanum (Zhang et al. 2004) . Interestingly, an α-L-arabinofuranosidase (AbfD3) that displays transglycosylation activity and is able to use p-nitrophenyl β-D-Galf as the sugar donor is found in Thermobacillus xylanilyticus (Remond et al. 2005) .
In prokaryotes, several Galf transferases have been identified, such as WbbI in E. coli that performs β1,6 coupling of Galf to α-glucose (Wing et al. 2006) and WbbO in K. pneumoniae that couples Galf in a β1,3 linkage to Galp (Guan et al. 2001 ). In addition, two Galf transferases have been identified in M. tuberculosis. GlfT1 is a bifunctional Galf transferase generating Galfβ1,5Galfβ1,4Rhaα1,3GlcNAcα1-P-P-decaprenyl, which is further elongated by GlfT2, another bifunctional enzyme that catalyzes the attachment of Galf in both β5-and β6-linkages (Mikusova et al. 2006; Belanova et al. 2008 ). As repeating β5-linkages have been identified in Aspergillus spp., an ortholog of this enzyme may be present in Aspergillus spp. However, our efforts (unpublished) and those of others to identify putative Galf transferases in eukaryotes by homology searches did not yield any potential candidates (Deshpande et al. 2008 ).
Glycosyl hydrolases acting on Galf-containing glycoconjugates
Aspergillus spp. are saprophytic and known to secrete different glycosyl hydrolases, which are able to degrade polysaccharides, derived from plants or other organisms, into smaller fragments that can be used by the fungus as a carbon or a nitrogen source. An interesting possibility would be that the fungus also exploits such enzymes to modify its exterior in order to escape the immune system of an infected host. The enzymatic activity of at least one galactofuranosyl hydrolase has been described in A. niger, but the responsible gene has not been identified (Cousin et al. 1989; Wallis et al. 2001b ). There is also evidence for the existence of an exo-β-D-galactofuranosidase in T. cruzi, but also in this species, no gene has been identified (Miletti et al. 2003) .
In addition to understanding their own functional relevance, the availability of specific Galf hydrolases would be very useful to study the biosynthesis and function of Galf-containing glycoconjugates. It was recently shown that thiodisaccharides with either Galf or arabinofuranose as terminal units could both inhibit the activity of an exogalactofuranosidase from Penicillium fellutanum, a very close relative of Aspergillus (Repetto et al. 2009 ). Other species that have been shown to possess galactofuranosyl hydrolase activity, but without identifying the responsible enzyme and gene, are Bacillus sp. (Ramli et al. 1995) , Helminthosporium spp. (Livingston and Scheffer 1983) , Penicillium charlesii (Rietschel-Berst et al. 1977) and Trichoderma harzianum (Van Bruggen-Van Der Lugt et al. 1992) .
Biological significance of Galf in eukaryotes
With the identification of genes involved in its biosynthesis, the role of Galf in eukaryotes has started to emerge in the last years. In eukaryotes, like in bacteria, Galf biosynthesis is crucial for the elaboration of the surface coat. But is it, as hypothesized from its distribution, a target for broad spectrum chemotherapeutic intervention?
Impact of Galf deficiency on cell morphology and growth Identification of the first eukaryotic proteins involved in Galf biosynthesis has allowed the generation of several Galf-deficient organisms. As expected, the deletion of genes encoding the UGM (glfA/ugmA) or encoding the UDP-Galf transporter (glfB/ugtA) confirmed the absence of alternative pathways for biosynthesis and transport into the Golgi of UDP-Galf and facilitated the in vitro characterization of the mutase enzyme activity. In all eukaryotes studied to date, the resulting absence of Galf led to profound changes of the glycocalyx or cell wall covering the plasma membrane.
In the protozoa L. major, the lack of the polysaccharide LPG, anchored to the membrane via a Galf-containing GPI, as well as the truncation of the abundant GIPLs, had no obvious effect on the morphology and growth of the parasite in vitro (Kleczka et al. 2007 ). In the closely related parasite T. cruzi, the biosynthesis of UDP-Gal is crucial for parasite morphology, growth and likely for its viability but the contribution of Galf remains to be determined (MacRae et al. 2006) .
In contrast, Galf deficiency in fungi results in manifest morphological changes and a growth reduction. Galf-negative strains containing either a mutated or deleted glf/ugm have been described in A. niger, A. nidulans and A. fumigatus (Damveld et al. 2008; El-Ganiny et al. 2008; Schmalhorst et al. 2008) . These strains present a compact aspect on solid media associated with a reduced radial growth and impaired conidiation. Germination, however, seems unaffected. In A. nidulans and A. fumigatus, an aberrant hyphal morphology with wide and highly branched hyphae has been reported (El-Ganiny et al. 2008; Lamarre et al. 2009) . Surprisingly, in the case of A. nidulans, these effects were partially remediated by addition of 10 μg/mL calcofluor white to the medium (El-Ganiny et al. 2008) . Galf-deficient A. niger exhibits a higher sensitivity to cell wall perturbating agents such as sodium dodecyl sulfate or calcofluor white. The loss of Galf residues in the cell wall of this species is counteracted by an increase in the expression of chitin and β-glucan synthesizing enzymes, which can be interpreted as a cell wall reinforcement mechanism to ensure the integrity of the cell wall (Damveld et al. 2008) . The effect on the cell wall thickness might however be variable. Using transmission electron microscopy, a substantial increase in the cell wall thickness of A. nidulans ΔugmA hyphae was described, whereas Galf-deficient A. fumigatus hyphae were shown to have a thinner cell wall by freeze-fracture scanning electron microscopy. Further studies are necessary to determine whether these differences represent structural variations or are due to the differences in techniques used.
Whereas the cell wall of A. fumigatus is relatively well characterized, the identity of Galf-containing molecules in the nematode C. elegans is still unknown. Nevertheless, it could be demonstrated that glf/ugm deletion leads to the absence of UDP-Galf biosynthesis and causes phenotypic changes Galactofuranose in eukaryotes indicative of an altered glycocalyx (Novelli et al. 2009) . A major defect observed in the mutant is the so-called Skiddy phenotype characterized by the broad and irregular trail left by the worm on an E. coli lawn. Beside this traction defect, the mutant worms show hypersensitivity to hypochlorite or proteinase K treatment and to osmotic stress. These observations, as well as the unusual surface affinity for numerous lectins, suggest that UGM plays a major role in the biosynthesis of the surface coat, a role supported by the spatial and temporal expression of UGM. Loss of UGM activity also causes morphological abnormalities such as body constrictions, a swollen post-anal region and superficial blisters. But most remarkably, UGM is essential for the late embryonic development. The embryonic lethality can be alleviated by enhancing tolerance to osmotic stress and might be due to permeabilization of the egg shell.
The eukaryotes studied to date demonstrate that the modification of the cell surface caused by the Galf absence often results in morphological abnormalities and a decreased fitness of the organism. Galf-deficient mutants are generally hypersensitive to drugs and exhibit a constitutive osmotic stress phenotype. However, the effects observed vary with the organism.
The role of Galf in virulence of eukaryotic pathogens
Despite the absence of a visible effect on the growth of L. major, the lack of Galf impacts the virulence of this parasite. Mice infected with the glf-deficient mutant present a delay of several weeks in the onset of lesions (Kleczka et al. 2007 ). Thereafter, the lesions develop normally. The delay in the establishment of the infection can be attributed to the loss of LPG since it is also observed with L. major parasites exclusively deficient in this polysaccharide, obtained by the deletion of the putative Galf-transferase LPG1 (Spath et al. 2003) . LPG is otherwise known to be essential within the insect vector for colonization of the gut and survival of the parasite (Sacks 2001; Naderer et al. 2004; Dobson et al. 2010) . It should be noted that LPG is only synthesized by the promastigote stage of the parasite present in the insect and transmitted by a sand fly bite. Within the mammalian host, Leishmania colonizes the macrophages and differentiates into replicating amastigotes rich in surface GIPLs. After the initial delay in lesion appearance, the regular disease progression induced by the L. major glf mutant suggests, however, that despite its abundance, Galf terminating the GIPLs does not play a crucial role in the infectivity and survival of the intracellular stage of the parasite. It should, moreover, be mentioned that the role of Galf cannot simply be extended to all Leishmania species since L. mexicana lacking LPG (as a consequence of LPG1 deletion) are not attenuated (Ilg 2000) .
Interestingly, in the related parasite T. cruzi, Galf-containing mucins have been found in strains of sylvatic origin Agrellos et al. 2003; Jones et al. 2004) , which are less infective than strains belonging to the domestic cycle expressing Galp-containing mucins (Burleigh and Andrews 1995; Previato et al. 1995; Pollevick et al. 2000; Todeschini et al. 2001) . The possibility that the presence of Galf would decrease the pathogenicity of the strains by affecting the capacity of the oligosaccharides to act as acceptors in the transsialidase reaction was tested recently. The presence of the Galf residue as an internal or a branching unit in the acceptor did not interfere with the sialylation of the compound by the transsialidase, suggesting that the introduction of Galf in the mucins of some T. cruzi strains would not be responsible for their diminished virulence (Agusti et al. 2007 ). However, it was found that sera from patients suffering from chronic Chagas disease recognize Galf-containing glycoproteins (Golgher et al. 1993) , and antibodies against terminal Galf epitopes inhibit T. cruzi internalization into mammalian cells (De Arruda et al. 1989) . These findings suggest that Galf may be important for antibody-mediated inactivation of the parasites by immune mammalian hosts. The β-galactofuranosyl residues of GIPLs and possibly other molecules likely also participate in the adhesion of T. cruzi to the midgut of its insect vector (Nogueira et al. 2007 ). Generation of a T. cruzi Galf-deficient mutant would allow determining if this unusual monosaccharide plays a role in the infectivity of this parasite.
The importance of Galf for fungal virulence has also been studied. The A. fumigatus glfA mutant displayed attenuated virulence in a low-dose mouse model of invasive aspergillosis. Intranasal inoculation of immunosuppressed female BALB/C mice with 20,000 conidia, derived from either a wild type or the ΔglfA A. fumigatus strain, showed that half of the mice infected with ΔglfA conidia were still alive on day 13, whereas the animals infected with wild-type conidia died before day 7. A similar study in which mice were infected with 10 5 conidia reported no difference in infectivity between wild type and the ΔglfA A. fumigatus strain (Lamarre et al. 2009 ). The inoculation dose may, however, influence the outcome of infection (Cortes et al. 2010 ) and a low dose is generally considered to mimic more closely the in vivo situation. Estimation of the fungal burden by quantitative polymerase chain reaction at a different time of infection indicates that the attenuated virulence of the ΔglfA mutant might be due to a slower growth inside the lungs. Histological analysis of the infected lung did not reveal any differences in the number of infiltrating leukocytes in the lungs (Schmalhorst et al. 2008) . Moreover, the mutant induced a normal cytokine response in murine macrophages, which argues against the galactomannan being a relevant pathogen-associated molecular pattern, at least in mice (Heesemann et al. 2011 ).
An altered immune response caused by the modified cell wall of the mutant may nevertheless contribute to the attenuation in virulence. Galf moieties may generally prevent the interaction of pathogen-derived glycoconjugates with host lectins. Removal of Galf from the surface of Aspergillus has indeed been shown to lead to the exposition of mannan resulting in an increased cellular adhesion to epithelial respiratory cells (Lamarre et al. 2009) . It has also been demonstrated that the C-type lectin DC-SIGN mediates binding and internalization of A. fumigatus conidia by dendritic cells and this process is inhibited when the soluble galactomannan is added (Serrano-Gomez et al. 2004 ). This DC-SIGN-mediated uptake was associated with a skewing of the immune system towards a Th2 response, as deduced from the induced cytokine profile. Since DC-SIGN is known to mediate the binding of mannosylated molecules (van Liempt et al. 2006) , leading to the induction of downstream intracellular signaling pathways B Tefsen et al. (Gringhuis et al. 2009) , it may be possible that the presence of mannose-linked Galf moieties such as found on fungal glycoconjugates influences the degree of DC-SIGN binding, thereby regulating host immune responses.
However, Galf might also play a role in host defense by interacting with the host immune system directly. Interestingly, Galf is immunogenic and often found in structures shed from the pathogen surface such as Leishmania LPG or Aspergillus galactomannan that could act as decoy diverting the host immune system. Another interesting possibility that should be confirmed by direct binding studies is that the C-type lectin Intelectin-1 recognizes Galf moieties. This lectin, which is a member of a large family of lectins identified in several chordates (Nishihara et al. 1986; Komiya et al. 1998; Tsuji et al. 2001) binds to the Galf-containing arabinogalactan from Nocardia in a Ca 2+ -dependent manner. Indirect binding studies suggest that Intelectin-1 has affinity for furanose residues, including Galf (Tsuji et al. 2001) . Intelectin-1 is found both as a soluble lectin and in lipid-raft domains in cells of the intestinal tract (Tsuji et al. 2001; Wrackmeyer et al. 2006; French et al. 2007 ). However, expression of Intelectin-1 can also be induced in the lungs, as was shown after infection with the lung parasite Nippostrongylus brasiliensis (Voehringer et al. 2007 ). The role of Galf in the immune response still deserves attention.
Medical and biotechnological relevance
The absence of Galf in human carbohydrates offers interesting possibilities to target this unusual compound in medical or biotechnological applications. An interesting question is whether increased understanding of the biosynthetic pathway and function of Galf-containing carbohydrates would facilitate more or improved applications in the future.
Galf as a target in medical applications
Since many years, the serodiagnosis of aspergillosis depends on the recognition of Galf (Stynen et al. 1995) . The sandwich-ELISA procedure that is routinely used for serodiagnosis aims at recognition of the Galf-containing galactomannan that is present in the serum of patients suffering from aspergillosis. Whereas this assay is very sensitive, there are reports that indicate cross-reactivity with other infectious fungi that possess Galf-containing glycoconjugates, like P. brasiliensis, H. capsulatum and Cryptococcus spp. (Xavier et al. 2009 ).
The alteration of the cell coat integrity and increased sensitivity to drugs seem to be common effects of Galf absence. However, the importance of Galf for virulence and survival of eukaryotic pathogens seem variable, and thus approaches that could be followed to develop Galf-based intervention therapies should be pathogen-specific. In the protozoan parasite L. major, Galf metabolism plays a role in LPG biosynthesis and thus in parasite survival and infectivity. However, this role seems to be restricted to the insect stage of the parasite. Nevertheless, inhibitors of UGM might be valuable to fight the medically relevant nematodes Brugia and Onchocerca. Like C. elegans, these parasites exhibit a glf/ugm homolog, but Galf-containing structures have not been demonstrated yet in these organisms (Beverley et al. 2005) . Galf-containing molecules might play a role in maintaining the integrity of the cell coat and for the embryonic development of these worms as is described for C. elegans (Novelli et al. 2009 ).
Whereas most fungi do not cause serious problems in healthy individuals, the current increase in immunocompromised patients causes an increase in infections with opportunistic fungal pathogens such as A. fumigatus. In addition, the cost and toxicity of antifungal drugs and the emerging resistance of the pathogens to antifungals restrict the therapeutic options. Therefore, improved strategies to fight fungal infections are required. In general, fungal cell wall metabolism provides useful targets for antifungal drug development, since the cell wall contains components that are unique to fungi and absent in plants and/or humans. Galf is found in the cell wall of many fungi, including the human pathogen A. fumigatus, and has been shown to be an essential component for a strong fungal cell wall. Interestingly, the A. fumigatus Galf-deficient mutant is more sensitive to drugs, notably to azoles. Its sensitivity to voriconazole, a front line drug that inhibits sterol biosynthesis in a dose-dependent manner and is used in the treatment of invasive aspergillosis, was increased 10-fold. The Galf metabolic pathways might thus be exploitable for the development of adjunct therapy against invasive aspergillosis.
In addition, the prevention of biofilm formation is an important strategy to counteract fungal infections. The galactomannan has been identified as an important component of the extracellular matrix of A. fumigatus which is formed during static growth conditions (Latge 2007) . The matrix resembles bacteria or yeast biofilms and is mainly composed of Galf-containing galactomannans and α-glucans (Loussert et al. 2010) . These biofilms are very resistant to antibiotic treatments and therefore their formation should be prevented. Growth conditions of pathogenic fungi in patients or mouse models resemble the static growth condition in vitro and include the formation of an extracellular matrix (Loussert et al. 2010) . It would be interesting to investigate whether Galf plays a role in biofilm formation by Aspergillus spp. as suggested by the compact aspect of the colony on plates (Damveld et al. 2008; Schmalhorst et al. 2008) . To identify the role of individual Galf-containing glycoconjugates in cellgrowth and host-pathogen interactions, the availability of mutants impaired in downstream acting genes, such as different putative Galf transferases, would be a great advantage.
Galf as a target in biotechnological applications
Galf appears to be a typical structural moiety within N-and O-glycans of Aspergilli ) and has also been observed on N-glycans of recombinant human α1 proteinase inhibitor produced by A. niger (Chill et al. 2009 ), one of the most important fungal species currently involved in the production of (glyco)proteins. Since Aspergilli strains totally devoid of Galf present a growth defect, targeting the galactofuranosyltransferases involved in glycoproteins modification might represent an alternative to optimize the use of A. niger as an expression system for pharmaceutical glycoproteins with a mammalian-like glycosylation pattern. Maintaining the galactofuranosylation of galactomannans and glycolipids might indeed lead to more robust strains. This, Galactofuranose in eukaryotes however, requires the further definition of galactofuranosylation in fungi.
Conclusions and perspectives
In conclusion, understanding of the biosynthetic pathway(s) leading to the formation of Galf-containing carbohydrates is important to enable the targeting of Galf in future applications. Whereas the first steps in Galf biosynthesis are rapidly being unraveled, understanding of the biosynthetic pathways in fungi is hampered due to the lack of knowledge about the Galf transferases, which catalyze the incorporation of Galf into different classes of carbohydrates. Because of the unique structure of Galf, we expect that the putative Galf transferases will be members of a novel glycosyltransferase family. Therefore, non-biased methods such as mutant screens, proteomic approaches and the use of biochemical Galf-transferase assays (Alderwick et al. 2008; Belanova et al. 2008 ) are required to identify these transferases. An essential component for the latter approach is the donor nucleotide sugar, UDP-Galf, which is not commercially available. Its synthesis has been described, either chemically (Marlow and Kiessling 2001; Mariño et al. 2005; Peltier et al. 2007) , enzymatically from its precursor, UDP-Galp, using E. coli K12 UGM (Lee et al. 1996) or using a combined chemoenzymatic approach . We expect that, similar to other glycosyltransferase families, identification of the first Galf transferase in Aspergillus will result in assigning other Galf-transferase genes as family members by a sequence identity. The successful identification of such a Galf-transferase family would stimulate and enhance future investigations of functional aspects of Galf-containing structures in Aspergillus and their medical and biotechnological applications.
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